NEW YORK, April 28, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Lyft, Inc. (“Lyft” or the “Company”) (NASDAQ: LYFT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW),…
Month: April 2024
NEW YORK, April 28, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against The Children’s Place, Inc. (“The Children’s Place” or the “Company”) (NASDAQ: PLCE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or…
NEW YORK, April 28, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Globe Life Inc. (“Globe Life” or the “Company”) (NYSE: GL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980 The investigation…
NEW YORK, April 28, 2024 /PRNewswire/ –Pomerantz LLP is investigating claims on behalf of investors of Li Auto Inc. (“Li Auto” or the “Company”) (NASDAQ: LI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, April 28, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of AXT, Inc. (“AXT” or the “Company”) (NASDAQ: AXTI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns…
NEW YORK, April 28, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Sealed Air Corporation (“Sealed Air” or the “Company”) (NYSE: SEE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, April 28, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Akero Therapeutics, Inc. (“Akero” or the “Company”) (NASDAQ: AKRO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, April 28, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Zevra Therapeutics, Inc. (“Zevra” or the “Company”) (NASDAQ: ZVRA). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, April 28, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of SeaStar Medical Holding Corporation (“SeaStar” or the “Company”) (NASDAQ: ICU). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980….
NEW YORK, April 28, 2024 Pomerantz LLP is investigating claims on behalf of investors of Harbor Diversified, Inc. (“Harbor” or the “Company”) (OTC: HRBR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns…
